Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Phio Pharmaceuticals (PHIO) Accumulated Depreciation & Amortization (2020)

Phio Pharmaceuticals' Accumulated Depreciation & Amortization history spans 1 years, with the latest figure at $72.0 million for Q4 2020.

  • For Q4 2020, Accumulated Depreciation & Amortization changed N/A year-over-year to $72.0 million; the TTM value through Dec 2020 reached $72.0 million, changed N/A, while the annual FY2020 figure was $72.0 million, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization reached $72.0 million in Q4 2020 per PHIO's latest filing.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $72.0 million in Q4 2020 to a low of $72.0 million in Q4 2020.